Premium
Study: Stem cell transplant should remain preferred therapy for multiple myeloma
Author(s) -
Printz Carrie
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30334
Subject(s) - bortezomib , medicine , multiple myeloma , melphalan , autologous stem cell transplantation , oncology , lenalidomide , regimen , transplantation , clinical trial , hematology , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom